Co-infections | Room 717

Saturday, June 16, 2018
10:30 AM to 12:15 PM

Chairs: Shruthi Mehta & Dave Wong

Invited Presentations:

10:30am
What will it take to eliminate HCV/HIV co-infection?
Natasha Martin, University of San Diego, La Jolla

10:55am
Progress towards HCV/HIV elimination
Marina Klein, McGill University, Montréal

11:20am
Controversies in Assessing Delta Hepatitis Epidemiology
Robert Gish, Stanford Health, Director of the Hepatitis B Foundation,  San Diego

11:45am
Early Hepatitis C Virus and IP-10 Kinetics During DAA Treatment with Sofosbuvir, Velpatasvir, and Voxileprevir in HCV Mono-infected and HIV/HCV Co-infected Persons
Mark Sulkowski, Johns Hopkins University, Baltimore 

Oral Abstracts:

12:00pm
Are hepatitis delta virus (HDV) genotypes important to determine the disease progression and therapy responses?
Michelle Spaan, King’s College Hospital, London

Return to Schedule